中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2010年
7期
27-29
,共3页
乳腺%导管内癌%个体化治疗
乳腺%導管內癌%箇體化治療
유선%도관내암%개체화치료
Breast%Ductal carcinoma in stiu%Individual treatme
目的 根据乳腺导管内癌的临床及病理特点探索其个体化治疗方式及其预后观察.方法 根据每例乳腺导管内癌的临床及病理特点采用个体化综合治疗方式,观察其预后.结果 本组67例患者根据肿块大小,术中冰冻病理切缘情况,来确定手术方式.其中象限切除术18例,肿块切除活检术10例,乳房单纯切除术16例或加Ⅰ期乳房假体植入术14例,乳腺肿块切除术+乳腺癌改良根治术4例,保乳术5例.术后辅助化疗33例,放疗23例,内分泌治疗42例.5年随访,2例死亡.不同术式组五年复发率和生存率无统计学差别.结论 导管内癌的治疗主要根据肿瘤大小来决定不同手术方式,同时结合肿瘤组织学特点、性激素受体等因素综合设计个体化治疗.
目的 根據乳腺導管內癌的臨床及病理特點探索其箇體化治療方式及其預後觀察.方法 根據每例乳腺導管內癌的臨床及病理特點採用箇體化綜閤治療方式,觀察其預後.結果 本組67例患者根據腫塊大小,術中冰凍病理切緣情況,來確定手術方式.其中象限切除術18例,腫塊切除活檢術10例,乳房單純切除術16例或加Ⅰ期乳房假體植入術14例,乳腺腫塊切除術+乳腺癌改良根治術4例,保乳術5例.術後輔助化療33例,放療23例,內分泌治療42例.5年隨訪,2例死亡.不同術式組五年複髮率和生存率無統計學差彆.結論 導管內癌的治療主要根據腫瘤大小來決定不同手術方式,同時結閤腫瘤組織學特點、性激素受體等因素綜閤設計箇體化治療.
목적 근거유선도관내암적림상급병리특점탐색기개체화치료방식급기예후관찰.방법 근거매례유선도관내암적림상급병리특점채용개체화종합치료방식,관찰기예후.결과 본조67례환자근거종괴대소,술중빙동병리절연정황,래학정수술방식.기중상한절제술18례,종괴절제활검술10례,유방단순절제술16례혹가Ⅰ기유방가체식입술14례,유선종괴절제술+유선암개량근치술4례,보유술5례.술후보조화료33례,방료23례,내분비치료42례.5년수방,2례사망.불동술식조오년복발솔화생존솔무통계학차별.결론 도관내암적치료주요근거종류대소래결정불동수술방식,동시결합종류조직학특점、성격소수체등인소종합설계개체화치료.
Objective To explore ductal carcinoma in stit individual treatment,according to clinical and pathological features of breast ductal carcinoma in situ.Methods Analysis of 67 cases of ductal carcinoma in situ in patients with clinical data.Results According to tumor size,intraoperative frozen pathology to determine the surgical method with 67 patients.Breast quadrant resection 18 cases,Breast tumor resection 10 cases,Breast tumor resection and Modified radical mastectomy 4 cases,Breast conserving surgery 5 cases.Postoperative adjuvant chemotherapy 33 cases,radiotherapy 23 cases,endocrine therapy 42 cases.Adjuvant treatment of patients with Chinese medicine.5-year follow-up,2 cases died of breast cancer recurrence,other patients were alive.5-year recurrence rate and 5-year survival rate were not statistically significant between different groups.Conclusion The treatment of ductal carcinoma in situ mainly based on tumor size,to determine the surgical method,combined with histological features hormone receptors to design individual treatment programs.